Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 12 | Issue 3 | 2021 | pp. 147–149Open access
Vancomycin-Induced Neutropenia with Fever
- 1,
- 1,
- 1*
- 1 Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Prayas Sethi
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Email: prayassethi82@gmail.com
Copyright: © 2021 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Nov 25, 2021
- Received:
- Jul 7, 2021
- Accepted:
- Aug 4, 2021
How to cite
Swain, S., Manjunath, M., & Sethi, P. (2021). Vancomycin-Induced Neutropenia with Fever. Journal of Pharmacology and Pharmacotherapeutics, 12(3), 147–149. https://doi.org/10.4103/jpp.jpp_84_21
Abstract
Vancomycin is a glycopeptide antibiotics acts by inhibiting cell well and is used for the treatment of resistant Gram-positive bacteria. Vancomycin-induced fever with neutropenia is not commonly encountered in our clinical practice, it can lead to diagnostic dilemmas during the course of management. We report the case of a 43-year-old female with infective endocarditis of the aortic valve, who was started empirically on vancomycin and ceftriaxone. She later developed fever with neutropenia following 2 weeks of intravenous antibiotics. This was attributed to the rare adverse effect of vancomycin, after further investigating and ruling out all other possible etiologies. After discontinuing vancomycin, the symptoms resolved rapidly. Although the exact mechanism of the fever and neutropenia is not known, many researchers believe it to be immune mediated.
Keywords
Subject
Article metadata
| Title | Vancomycin-Induced Neutropenia with Fever |
|---|---|
| Authors | Satish Swain; Mouna Manjunath; Prayas Sethi |
| Affiliations | Department of Medicine, All India Institute of Medical Sciences, New Delhi, India. |
| Corresponding author | prayassethi82@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 12, Issue 3 (2021) |
Also in this issue
- 2-Deoxy-D-Glucose: A Ray of Hope in COVID Pandemicpp. 107–109
- Effect of Homoharringtonine as a Combined Regimen for Acute Myeloid Leukemiapp. 110–114
- Hurdles in Mandatory Generic Medicine Prescriptionpp. 115–119
- A Mini Review: Mucormycosis in Coronavirus Disease-19, Host-Iron Assimilation, and Probiotics as Novel Therapypp. 120–124
- A Single-Center, Observational, Retrospective Cost-Effective Analysis of Treating Inadequately Controlled Type 2 Diabetes Mellitus by Addition of DPP4 Inhibitors Versus Intensified Treatment with Conventional Drugspp. 125–130
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026